There is an observability gap - literally a black hole in our ability to see, understand and monitor our clinical data. In clinical R&D, the observability gap is responsible for delays in clinical trials of 6-18 months. A trillion $/year life science industry still relies on manual data processing for R&D. This manual work delays cures for patients, revenue for companies and competitive advantage. 10 days in Corona time is 20,000 lives. Every day counts.

1. Investor Deck
December 2020
Collect | Detect | Act
Observability for clinical data

2. Source: FDA Performance goals, Deloitte 2020 Global life sciences outlook, “Why clinical trial outcomes fail to translate into benefits for patients”, Heneghan et al
Summer 2016. A WTF moment.
19%
Of clinical trials miss
their endpoints.
R&D failure.
Collect | Detect | Act
6-18
Months delay
to market
Pivotal study
Paper & briefcase
No data monitoring
Manual data cleanup - 6 months
1MB data
#corona-time

3. Observability problem in clinical data
Collect | Detect | Act
Data Events
Observability gap
Hours Months
6-18
Valid data?
Custom solutions
China, India, USA - 294M wearable devices, 27% YOY

4. Collect | Detect | Act
Our key value proposition
Data Events
Automated detect & act on clinical data
1
Now
isAnomaly: ’t'
#observe-clinical-data
Zero-admin clinical data anomaly detection in an open API

5. Collect | Detect | Act
1
Act
Detect
Collect
2
3
Data
anywhere,
anytime
AI-driven
event
detection
Same day
response
Same day delivery
#coronatime

6. Collect | Detect | Act
Collaborators
HealthSuite digital platformSingHealth
• 35 clinical trials
• 3 FDA approvals
• 9M signals
• 11394 alerts
• 6200 patients

7. Collect | Detect | Act
The ratio of compliance with the protocol is
extremely high, and with the real-time alerts, we
fix patient issues in a ‘short-loop’.
This is a wonderful feature, and it makes the
difference between a futile study and a
successful one”.
Alon Ironi
CEO, Theranica Therapeutics
Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications.
Rapoport et al. The Journal of Headache and Pain.
Migraine treatment case study
5M patient/device signals
NCT03361423
253 patients
95% compliance
5’ to endpoints (1)
(1) 95% of patient data from migraine sessions is collected digitally from handset via BLE from wearable device and transmitted via Flask API to the Flask platform.
A second API process on the platform computes endpoints like Photophobia and updates the EDC within 5’ after patient reports outcomes.

8. Collect | Detect | Act
CHF case study
Pickup payer data
Collect | Detect
Anomalies
647
Signals
3.1K

9. Observability for the world of IOB
• Unsupervised anomaly detectionOne size
Fits all • Affordable for connected device market
• OpenAPI

10. Collect | Detect | Act
Our TAM
Identified segments
Market data sources:
1. Statista
USA
16%
India
27%
China
57%
$5BN Internet of Bodies (IOB)
observability market
100
733.333
1366.667
2000
2020 2021 2022 2023
1,403
1,105
929
835
Worldwide connected wearable devices
(millions)
Assumption: $3/endpoint/year

11. Collect | Detect | Act
Jenya Konikov-Rozenman
Co-founder. Delivery
Duchenne researcher
Danny Lieberman
Founder. CEO
Physicist & Serial entrepreneur
Eugene Kalosha
Architect
PhD AI Research
Rivka Rot
Data pipeline
Fraud & big data
Dr Dan Peres
Co-founder. Product
Medical & clinical
Why us?

12. Questions?
Danny Lieberman - Founder & CEO
dannyl@flaskdata.io

13. Collect | Detect | Act
Forecast ARR
0
22.5
45
67.5
90
2022 2023 2024 2025 2026
58
23
12
21
Revenue(M)
Market
penetration
0.07% 0.33% 1.33% 2.0% 4.0%
# of IOB 260K 1.56M 8M 15.3 38.85M
• $3/endpoint/year
• Subscription auto
renew at 12 month
• 50% to channel
• Identified segments
• CAGR 27%
Assumptions